These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16086642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J, McCusker S, Lang K, Grosse S, Mace A, Lumley R, Kubba H.
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of oral secretions in neurological disease.
    McGeachan AJ, Mcdermott CJ.
    Pract Neurol; 2017 Apr; 17(2):96-103. PubMed ID: 28188210
    [Abstract] [Full Text] [Related]

  • 7. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].
    Hernández-Palestina MS, Cisneros-Lesser JC, Arellano-Saldaña ME, Plascencia-Nieto SE.
    Cir Cir; 2016 Apr; 84(6):459-468. PubMed ID: 27221328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 11. Botulinum Toxin in the Management of Sialorrhoea in Acquired Brain Injury.
    Carrol A, McGlone B.
    Ir Med J; 2016 Jun 10; 109(6):425. PubMed ID: 27814442
    [Abstract] [Full Text] [Related]

  • 12. Sialorrhea in Parkinson's Disease.
    Isaacson J, Patel S, Torres-Yaghi Y, Pagán F.
    Toxins (Basel); 2020 Oct 31; 12(11):. PubMed ID: 33142833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E, Karlsborg M, Bardow A, Lykkeaa J, Nissen FH, Bakke M.
    Acta Odontol Scand; 2011 May 31; 69(3):151-7. PubMed ID: 21198339
    [Abstract] [Full Text] [Related]

  • 16. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.
    Molloy L.
    Curr Opin Neurol; 2007 Aug 31; 20(4):493-8. PubMed ID: 17620887
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA, Panebianco M, Casabona A, Lanza S, Marchese-Ragona R, Patti F, Masiero S, Biondi A, Quartarone A.
    Toxins (Basel); 2018 Jan 27; 10(2):. PubMed ID: 29382036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.